In an effort to reduce readmissions and costs, CVS Health has launched a program to help patients with knee replacements.
CVS Health announced a pilot program designed to improve outcomes for knee replacement patients.
The program, in concert with CVS Health’s recently-purchased Aetna, will allow patients to meet with case managers at select CVS locations to discuss potential sticking points. These include making sure a surgeon is in network or performing a home assessment.
Aetna spokesperson Ethan Slavin says the program could lead to better outcomes and lower costs: “We believe that this program can create an improved experience for members going through knee replacement and improve health outcomes over time. Avoiding hospital readmission, especially after surgery, can also result in significant medical cost savings.
Slavin says that the program will hopefully help patients both better prepare for surgery and recover after.
While there aren’t currently plans for expanding the program, Slavin says it’s something the company is exploring, possibly even including other conditions.
FDA Updates for Week of May 13: First Bispecific Antibody for Solid Tumor
May 18th 2024The FDA has approved a new type of bispecific antibody to treat small cell lung cancer and an additional indication for Breyanzi for patients with follicular lymphoma. The agency has set review date for gene therapy for enzyme deficiency. In addition, Biogen have Eisai hve begun a rolling submission of subcutaneous Leqembi for Alzheimer’s disease.
Read More
Omega-3s For Dry Eye Disease? Not the Answer According to This Study
May 17th 2024Some research has suggested that omega-3 fatty acid supplements could help treat dry eye disease. But Korean investigators reported results from a randomized clinical trial this week in JAMA Ophthalmology tthat showed no benefit.
Read More